Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.
Fluor posted adjusted earnings of 68 cents per share, beating market estimates of 57 cents per share. The company’s quarterly sales came in at $3.82 billion versus expectations of $4.11 billion.
Fluor shares declined 7.7% to $38.84 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers
- TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares jumped 214% to $13.00. TRxADE HEALTH announced the sale of assets of subsidiary Trxade, Inc. to Micro Merchant Systems for $22.5 million, with potential additional $7.5 million payout.
- AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) surged 203% to $0.6487. AgriFORCE was granted patent from the USPTO related to its FORCEGH+ facilities.
- Monopar Therapeutics Inc. (NASDAQ: MNPR) shares jumped 170% to $0.9130. Monopar received clearance to proceed with first-in-human Phase 1 trial of novel radiopharmaceutical MNPR-101-Zr in advanced cancers.
- Biofrontera Inc. (NASDAQ: BFRI) gained 125% to $1.69. Biofrontera announced restructuring of supply agreement with Biofronter AG. Biofrontera also announced a $16 million private placement.
- Biotricity, Inc. (NASDAQ: BTCY) rose 72.7% to $1.59.
- Shineco, Inc. (NASDAQ: SISI) shares climbed 71.8% to $2.5232 after surging more than 16% on Friday. Shineco recently announced plans for a 1-for-10 reverse stock split to regain compliance with Nasdaq minimum bid requirement.
- SciSparc Ltd. (NASDAQ: SPRC) gained 52.7% to $5.32. SciSparc reported that as part of its ongoing collaboration with Clearmind Medicine, Clearmind filed three patent applications under the international Patent Cooperation Treaty.
- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) shares rose 37% to $12.55. WuXi Advanced Therapies announced Tuesday that the U.S. Food and Drug Administration (FDA) approved it to begin analytical testing and manufacturing of AMTAGVI for Iovance Biotherapeutics at its Philadelphia site. AMTAGVI received accelerated approval of its BLA on Feb. 16. Iovance also announced on Tuesday the pricing of an underwritten offering of 23,014,000 shares of its common stock at a price of $9.15 per share.
- CISO Global Inc. (NASDAQ: CISO) jumped 36% to $0.1359. CISO Global announced independent valuation of over $50 million for its initial IP solutions portfolio.
- Intuitive Machines, Inc. (NASDAQ: LUNR) surged 30% to $9.51.
- MoneyHero Limited (NASDAQ: MNY) gained 26% to $2.6599.
- Enviva Inc. (NYSE: EVA) shares gained 19.3% to $0.39 after falling around 12% on Friday. The Wall Street Journal recently reported that Enviva was preparing to file for bankruptcy.
- CURO Group Holdings Corp. (NYSE: CURO) surged 19.1% to $0.28.
- Ocugen, Inc. (NASDAQ: OCGN) gained 18% to $1.12 after jumping 27% on Friday.
- VIZIO Holding Corp. (NYSE: VZIO) surged 14.8% to $10.94 after the company inked an agreement to be acquired by Walmart.
- Discover Financial Services (NYSE: DFS) shares rose 12% to $13.00. Capital One Financial Corp (NYSE: COF) announced its plans to purchase Discover Financial Services, marking a pivotal $35.3 billion all-stock transaction.
- Barclays PLC (NYSE: BCS) surged 11.7% to $8.35 after the company reported fourth-quarter financial results and announced its intention to initiate a further share buyback of up to £1 billion.
- Qurate Retail, Inc. (NASDAQ: QRTEA) jumped 10.6% to $1.15.
- Telephone and Data Systems, Inc. (NYSE: TDS) gained 7.7% to $15.13. The company recently reported fourth-quarter financial results and issued FY24 guidance.
- D-Wave Quantum Inc. (NYSE: QBTS) shares gained 7.4% to $1.8692. NEC and D-Wave introduced new quantum offerings to the Australian market.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares fell 62.6% to $9.75 as the company announced a clinical hold on studies evaluating zelnecirnon.
- MicroCloud Hologram Inc. (NASDAQ: HOLO) shares fell 32.9% to $44.60 after jumping 114% on Friday.
- Summit Therapeutics Inc. (NASDAQ: SMMT) fell 24.4% to $3.8350 following fourth-quarter results.
- Universe Pharmaceuticals INC (NASDAQ: UPC) shares fell 24% to $1.87 after gaining around 44% on Friday.
- VirnetX Holding Corporation (NYSE: VHC) dipped 23.4% to $7.05.
- Sientra, Inc. (NASDAQ: SIEN) fell 23.4% to $0.2330.
- Better Therapeutics, Inc. (NASDAQ: BTTX) declined 22% to $0.17. Better Therapeutics received FDA breakthrough device designation for digital therapeutic platform targeting advanced liver disease.
- AirNet Technology Inc. (NASDAQ: ANTE) fell 21.5% to $0.9499.
- Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares fell 21.2% to $7.49. Tevogen Bio recently announced an $8 million equity investment.
- Tantech Holdings Ltd (NASDAQ: TANH) fell 20.6% to $0.7701.
- Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares fell 20.3% to $0.6760 after gaining 42% on Friday.
- Tenaya Therapeutics, Inc. (NASDAQ: TNYA) dipped 18% to $5.18.
- Gaxos.ai Inc. (NASDAQ: GXAI) shares declined 17.3% to $0.5830 after surging 173% on Friday. The company announced that its gaming division will launch an AI solution for game developers and studios.
- Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) fell 16.4% to $4.370. Evolv Technology responded to short seller misinformation.
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) fell 13.3% to $2.7590.
- Super Micro Computer, Inc. (NASDAQ: SMCI) fell 12.7% to $700.61. Supermicro announced expansion of AI solutions portfolio.
- FLJ Group Limited (NASDAQ: FLJ) shares tumbled 11.8% to $1.04. FLJ Group filed annual report on Form 20-F for fiscal year 2023.
- InMode Ltd. (NASDAQ: INMD) fell 11.4% to $20.19.
- Lichen China Limited (NASDAQ: LICN) dipped 10.8% to $1.24 after gaining around 19% on Friday.
- Opendoor Technologies Inc. (NASDAQ: OPEN) fell 9.7% to $2.7100.
- Arm Holdings plc (NASDAQ: ARM) fell 8.1% to $117.99.
- The Trade Desk, Inc. (NASDAQ: TTD) fell 7.6% to $82.18.
- Oriental Culture Holding LTD (NASDAQ: OCG) shares fell 7.4% to $1.04 after gaining 21% on Friday.
- SSR Mining Inc. (NASDAQ: SSRM) fell 7.3% to $4.55. SSR Mining is expected to release its fourth quarter financial results on Feb. 27, 2024. The company also issued an update on ongoing rescue efforts at the Çöpler mine in Türkiye. RBC Capital analyst Michael Siperco downgraded SSR Mining from Sector Perform to Underperform and lowered the price target from $6 to $3.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: Ethereum Tops $2,900; Starknet, Filecoin Among Top Gainers
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.